2.65

2.21% -0.06

Cronos Group Inc (CRON)

Overview News Price History Option Chain Financials Discussions Forecast

Cronos Group Inc stock is traded at $2.65, with a volume of 776.48K. It is down -2.21% in the last 24 hours and down -3.28% over the past month. Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

Previous Close:

$2.71

Open:

$2.69

24h Volume:

776.48K

Relative Volume:

0.53

Market Cap:

$990.20M

Revenue:

$159.54M

Net Income/Loss:

$5.06M

P/E Ratio:

-602.27

EPS:

-0.0044

Net Cash Flow:

$26.19M

1W Performance:

+0.76%

1M Performance:

-3.28%

6M Performance:

-4.68%

1Y Performance:

+42.47%

1-Day Range:

$2.65

$2.725

1-Week Range:

$2.57

$2.725

52-Week Range:

$1.84

$3.43

Cronos Group Inc Stock (CRON) Company Profile

Name

Cronos Group Inc

Sector

Healthcare (1108)

Industry

Drug Manufacturers - Specialty & Generic (85)

Phone

(416) 504-0004

Address

4491 CONCESSION RD 12, STAYNER, ON

Employee

610

Twitter

@cronosgroup

Next Earnings Date

2026-08-06

Latest SEC Filings

CRON's Discussions on Twitter

Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRON Cronos Group Inc	2.65	1.01B	159.54M	5.06M	26.19M	-0.0044
TAK Takeda Pharmaceutical Co Adr	15.47	49.39B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	8.77	39.55B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	32.20	36.66B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.89	33.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	538.30	22.78B	3.17B	1.29B	1.01B	27.09

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-27-26	Initiated	Canaccord Genuity	Buy
Nov-02-22	Initiated	Bernstein	Mkt Perform
Jul-28-22	Upgrade	Canaccord Genuity	Hold → Buy
May-11-22	Upgrade	CIBC	Neutral → Sector Outperform
Mar-22-22	Upgrade	Barclays	Underweight → Equal Weight
Jan-27-22	Upgrade	Jefferies	Underperform → Hold
Nov-18-21	Resumed	BofA Securities	Underperform
Apr-28-21	Resumed	BofA Securities	Underperform
Feb-22-21	Downgrade	CIBC	Sector Outperform → Neutral
Jun-24-20	Upgrade	Raymond James	Mkt Perform → Outperform
Apr-27-20	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-14-20	Downgrade	Piper Sandler	Overweight → Neutral
Apr-02-20	Downgrade	BofA/Merrill	Buy → Neutral
Mar-31-20	Downgrade	Canaccord Genuity	Hold → Sell
Mar-04-20	Upgrade	MKM Partners	Neutral → Buy
Mar-03-20	Downgrade	Stifel	Buy → Hold
Oct-18-19	Upgrade	Stifel	Hold → Buy
Sep-20-19	Initiated	MKM Partners	Neutral
Sep-05-19	Upgrade	BMO Capital Markets	Underperform → Market Perform
Aug-13-19	Initiated	Piper Jaffray	Overweight
Aug-09-19	Upgrade	Canaccord Genuity	Sell → Hold
Jun-28-19	Initiated	Consumer Edge Research	Equal Weight
Jun-06-19	Initiated	Stifel	Hold
Jun-05-19	Upgrade	BofA/Merrill	Underperform → Buy
Apr-17-19	Initiated	BofA/Merrill	Underperform
Mar-27-19	Downgrade	Canaccord Genuity	Hold → Sell
Feb-25-19	Initiated	Jefferies	Underperform
Jan-18-19	Initiated	CIBC	Sector Outperform

View All

Cronos Group Inc Stock (CRON) Latest News

Jun 22, 2026